ShareValue scores for 301331.SHE: Valuation 50, Quality 38, Growth 44, Health 56.
301331.SHESZSE
Enwei Pharmaceutical Co. Ltd. A
CN¥21.29
(+1.91%)
301331.SHESZSE
Enwei Pharmaceutical Co. Ltd. A
CN¥21.29(+1.91%)
Loading chart...
Sentiment
Verdicts
Value:Fair Value
Quality:Weak
Growth:Moderate
Health:Moderate
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
5% to 16%
Rating
Trap Risk
Return
5% to 16%
Valuation
50
Fair Value
Price vs Value
Quality
38
Weak
Business Strength
Growth
44
Moderate
Revenue & Earnings
Health
56
Moderate
Financial Stability
Momentum
25
Bearish
Price Trend
Company Details
About
Enwei Pharmaceutical Co., Ltd. engages in the development and sale of Chinese medicines in China. The company offers drugs in the areas of gynecology, pediatrics, and respiratory system fields. The company was founded in 2005 and is based in Chengdu, China.
Market Cap$2.19B
P/E Ratio45.7
Dividend Yield3.19%
Sector Rank#1927
Score Analysis
AI Investment Thesis
Data as of:Aug 7, 2026
|Last calculated:Aug 7, 2026